Significance of Apolipoproteins for the Biochemical Profile of Atherosclerosis

  • P. Avogaro
  • G. Bittolo Bon
  • F. Belussi
  • G. Cazzolato
  • E. Pontoglio
Conference paper

Abstract

The experimental induction in animals of a pattern similar to human atherosclerosis through a cholesterol-enriched diet and the finding of high plasma cholesterol levels in population groups at high risk for coronary disease suggested a close link between human atherosclerosis and hyperlipidemia. This underlies the “lipid hypothesis” of atherogenesis. A contributory factor in this were the epidemiological surveys that have flourished in recent years, all of which have pointed to a lipid parameter or to a ratio between lipid parameters as the best biochemical marker of coronary risk. From time to time total cholesterol (1), LDL-C (2), HDL-C (3) and the LDL-C/HDL-C ratio (4) have taken turns as the best discriminator of coronary risk. If we look however to studies performed in large series of atherosclerotic patients we can observe that a hyperlipidaemic state is not frequently recorded. Gotto et al. (5) have recorded a significant plasma cholesterol gradient with advancing coronary occlusion, but the values were always within normal confidence limits. Goldstein et al (6) had observed a hyperlipidemia in only 31% of their series of 500 survivors.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    KANNEL W.B., DAWBER T.R., KAGAN A., REVOTSKIE N., STOKES J. Factors or risk in the development of coronary heart disease. Six years follow-up experience. Ann. Int. Med. 1961; 55; 33–50PubMedGoogle Scholar
  2. 2.
    KANNEL W.B., CASTELLI W.P., GORDON T., MAC NAMARA P.M. Serum cholesterol, lipoproteins and the risk of coronary heart disease: The Framingham Study. Ann. Int. Med. 1971; 74: 1–12PubMedGoogle Scholar
  3. 3.
    CASTELLI W.P., DOYLE J.Y., GORDON T.G., HAMES C.G., HJORTLAND M.C. HULLEY S.B., KAGAN A., ZUKEL W.J. HDL-Cholesterol and other lipids in coronary heart disease. The Cooperative Lipoprotein Phenotyping Study. Circulation 1977; 55: 767–772PubMedGoogle Scholar
  4. 4.
    KANNEL W.B, CASTELLI W.P. Is the serum total cholesterol an anachronism? Lancet 1979; ii: 950–951CrossRefGoogle Scholar
  5. 5.
    GOTTO A.M., GORRY G.A., THOMPSON J.R., COLE J.S., TROST R., YESKURUN D., DE BAKEY M.E. Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation 1977; 56: 875–883PubMedGoogle Scholar
  6. 6.
    GOLDSTEIN J.L., HAZZARD W.R., SCKROTT H.G., BIERMAN E.L., MOTULSKY G., LEVINSKI M.J., CAMPBELL E.D. Hyperlipidemia in Coronary Heart Disease. I. Lipid Levels in 500 survivors of myocardial infarction. J. Clin. Invest. 1973; 52: 1533–1543PubMedCrossRefGoogle Scholar
  7. 7.
    AVOGARO P., CAZZOLATO G., BITTOLO BON G:, BELUSSI F. Levels and chemical composition of HDL2 HDL3 and other major lipoprotein classes in survivors of myocardial infarction. Artery 1979; 5: 495–508Google Scholar
  8. 8.
    AVOGARO P., BITTOLO BON G., CAZZOLATO G., QUINCI G.B. Are apolipo proteins better discriminators than lipid for atherosclerosis’? Lancet 1979; i: 901–903CrossRefGoogle Scholar
  9. 9.
    AVOGARO P., CAZZOLATO G., TARONI G., BELUSSI F. Chemical composition of ultracentrifugal fractions in different patterns of human atherosclerosis. Atherosclerosis 1977; 26: 163–172PubMedCrossRefGoogle Scholar
  10. 10.
    KLADETZKY R.G., ASSMANN G., WALGENBACH S., TAUCHERT P., HELB H.D. Lipoprotein and apoprotein values in coronary angiography patients. Artery 1980; 7: 191–205PubMedGoogle Scholar
  11. 11.
    RIESEN W., MORDASINI R., SALZMANN C. a. GURTNER H.P. Apoproteins in angiographically documented coronary heart disease In Lipoproteins and Coronary Atherosclerosi (Noseda C., Fragiacomo C., Fumagalli R. and Paoletti R. Eds). Elsevier Biomedical Amsterdam 1982, 129Google Scholar
  12. 12.
    AVOGARO P., BITTOLO BON G., CAZZOLATO G. Need for new classification of lipoprotein derangements in human atherosclerosis. Lancet 1981; i: 1257CrossRefGoogle Scholar
  13. 13.
    SNIDERMAN A., SHAPIRO GL, MARPOLE D., SKINNER B., TENG B., KWITEROVICH P.O. Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (B) lipoproteins). Proc. Natl. Acad. Sci. USA 1980; 77: 604–608PubMedCrossRefGoogle Scholar
  14. 14.
    KWITEROVICH P., SNIDERMAN A,. FORTE T., BACHORIK P., CHATTERJEE S. Familial hyperapobetalipoproteinemia in a Amish Kindred. Arteriosclerosis (abs) 1981; 1: 87Google Scholar
  15. 15.
    FRANCESCHINI G., BONDOLIA., MANTERO M., SIRTORI M., TATTONI G., BIASI G., SIRTORI C.R. Increased apoprotein B in very low density lipoproteins of patients with peripheral vascular disease Arteriosclerosis 1982; 2: 74–80PubMedCrossRefGoogle Scholar
  16. 16.
    VERGANI C., BETTALE G. Familial hypo-alpha-lipoproteinaemia. Clin. Chim. Acta 1981; 114 45–52CrossRefGoogle Scholar
  17. 17.
    LAKIER J., GOLDSTEIN S., NORUM R., BLOCK W., GOLDBERG R. Premature atherosclerosis associated with apolipoprotein A-I deficiency, Detroit type. Atherosclerosis (abs) 1981: i: 367aGoogle Scholar
  18. 18.
    SCHAEFER E.J., HEATON W.H., WETZEL M.G., BREWER H.B. Jr. Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis 1982; 2: 16–26PubMedCrossRefGoogle Scholar
  19. 19.
    ISHIKAWA T., FIDGE N., THELLE D.S., FORDE O.H., MILLER N.E. The Trømso Heart Study: Serum apolipoprotein A-I concentration in relation to future coronary heart disease. Europ. J. Clin. Invest. 1978; 8: 179–182PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • P. Avogaro
  • G. Bittolo Bon
  • F. Belussi
  • G. Cazzolato
  • E. Pontoglio

There are no affiliations available

Personalised recommendations